Parenteral Nutrition Market Size By Composition (Amino Acids, Fats, Carbohydrates, Trace Elements, Vitamins, Minerals), By Consumer (Children and Newborns, Adults), By End-use (Hospitals, Clinics, Homecare), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Published Date: Aug 2021  |  Report ID: GMI3216  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 165   |   Base Year: 2020




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Parenteral Nutrition Market size was valued at over USD 5.3 billion in 2020 and is anticipated to grow at a CAGR of more than 7.4% between 2021 and 2027. Rapidly increasing elderly population and growing rate of pre-mature births across the globe is predicted to stimulate the demand for parenteral nutrition products. The favourable government initiatives in various countries such as the Germany’s national initiative to promote nutritional awareness are further estimated to upsurge the market growth.
 

Parenteral Nutrition Market Overview

Get more details on this report - Request Free Sample PDF
 

However, lack of awareness in developing countries such as India and other countries in Latin America & Asia regarding various effective parenteral nutrition practices to improve patient health may hamper the market expansion. This lack of knowledge pertaining to parenteral nutrition results in nutritional deficiency, thereby surging the risk of chronic diseases. Lack of clinical evidence to support novel technology in parenteral nutrition compounding are some other factors that may slow down the industry growth. Also, increased use of enteral nutrition is another major factor restricting the market progression.
 

The outbreak of the COVID-19 virus is an unprecedented health issue across the globe and has also affected the parenteral nutrition market value. Parenteral nutrition executed a significant role in treating the COVID-19 infection-related malnutrition in patients worldwide. In 2020, the European Society for Clinical Nutrition and Metabolism established a guideline pertaining to the nutritional management of people infected with SARS-CoV-2 infection. As per the article published in 2020, the COVID-19 infection resulted in a severe lack of appetite coupled with other symptoms that led to an increase in loss of muscle mass and a deterioration of immune defences. As a response to this condition, the hospitals and clinics have raised the availability of healthcare units for patients that require disease-specific nutrition. Such developments are poised to upsurge the demand and adoption of intravenous administration of nutrition in patients.
 

However, the travel restrictions imposed by governments in various countries, cancellation of elective procedures, and allotment of dedicated facilities for COVID-19 patients has substantially reduced the inpatient volume throughout this period. Further, market players across the globe witnessed delay or cancellation in launch of novel parenteral nutrition products.
 

Growing prevalence of malnutrition across the globe is slated to augment the parenteral nutrition market revenue

Rising prevalence of malnutrition across the globe has led to an increase in demand for parenteral nutrition to increase energy, hydration, and strength of undernourished patients is expected to drive the industry progression positively. Moreover, the favorable government initiatives to reduce the burden of malnutrition also resulted in high intravenous feeding demand. Several government organizations including Food4Africa, Action Against Hunger, Heifer International, and World Health Organization among others are focusing to provide effective treatment for malnourished individuals.
 

Clinical use of amino acids as dietary supplement will accelerate the market demand

The amino acids segment exceeded USD 2.03 billion in 2020 led by the growing awareness related to the importance of amino acids in human nutrition and the rising prevalence of protein-energy malnutrition diseases, etc. Amino acids are highly used as a source of energy owing to their capability to treat mental fatigue, sprain, and muscle soreness among others. According to the research article published in 2021, around 18 million children are suffering from kwashiorkor and marasmus disorder in low-income or middle-income countries with the majority in Asia. Thus, rising protein deficiency among individuals that requires the administration of amino acid rich intravenous feeding will spur the industry value.
 

Increasing rate of pre-mature birth will boost the market progression

The children and newborns segment in the parenteral nutrition market accounted for 43% of revenue share in 2020 impelled by the growing rate of pre-mature birth in developing countries, growing undernutrition among children, etc. Majority of premature births are reported in the developing countries comprising India, Nigeria, Indonesia, Philippines, etc. In India, over 3 million babies are born premature that accounts for 13% of births in the country every year. Furthermore, the rising prevalence of chronic ailments including cystic fibrosis, congenital heart diseases, and cerebral palsy among others has created opportunities for key participants to invest in the market.
 

Rise in demand and preference for homecare will augment the market growth

Parenteral Nutrition Market Size

Get more details on this report - Request Free Sample PDF

 

The homecare end-use segment is slated to observe 7.2% growth rate through 2027 on account of the growing elderly population, rising patient preference for home-based care, increasing demand for cost effective healthcare delivery, etc. In the APAC region, the population of elderly people aged 60 years or above was around 9% in 2017 and is set to increase to over 13% and 20% by 2030 and 2050 respectively. Additionally, according to the American Geriatrics Society and British Geriatrics Society, homecare reduces the risk of rehospitalisation that is predicted to propel the segment expansion in the coming years. The COVID-19 infection has further increased the acceptance of parenteral nutrition products in home care settings, thereby driving the industry revenue during the forecast period.
 

Growing awareness in the North America region to curb the chronic diseases burden is poised to boost the regional growth

Global Parenteral Nutrition Market

Get more details on this report - Request Free Sample PDF

 

U.S. dominated the North America parenteral nutrition market with a majority of share in 2020 and is projected to reach USD 1.70 billion by 2027 owing to the multiple factors such as rising metabolic disorders & other chronic diseases, favorable government initiatives, growing malnutrition, etc. As per the statistics by a report published in 2020, an estimated 65,630 people were diagnosed with head and neck cancer in the U.S. According to the World Bank data, in 2018, in the U.S., around 1% of children were affected attributed to chronic malnutrition and 2.5% of population suffered due to undernourishment. Such patients are recommended to undergo intravenous feeding.
 

Germany market will capture USD 391 million by 2027 driven by the increase in number of people suffering from chronic ailments, growing elderly population, and rising healthcare expenditure among others. As per Globocan, in 2020, the number of people diagnosed with cancer were 628,519 in Germany. In Germany, around 38% of the population is expected to be aged 60 years and over by 2050.
 

Strategic initiatives implemented by prominent players is anticipated to impel the market expansion

Some of the major companies operating in the market are Amanta Healthcare, Anhui Medipharm Co., Ltd., Fresenius Kabi AG, Aculife Healthcare, Baxter International, Inc., and B. Braun Melsungen AG among others. These prominent leaders focus on strategic partnerships, new product launch & commercialization for business expansion. In addition, these participants are investing in research and development activities along with regional expansion plans that allow them to garner maximum revenue share.
 

Recent industry developments:

  • In October 2018, Fresenius Kabi AG announced the launch of SmofKabiven extra Nitrogen, a sterile and hypertonic emulsion for intravenous nutrition, in Europe. This product launch helped the company in strengthening its product offerings and bolstered its industrial presence.
     
  • In April 2016, Baxter International, Inc. received marketing authorization for its product NUMETA G13E in UK and Denmark. The NUMETA G13E is indicated for intravenous nutrition administration for preterm new-borns. This strategic move strengthened the company’s market position in the UK and Denmark and further assisted in the revenue growth.
     

Parenteral nutrition market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Composition, 2016 - 2027 (USD Million)

  • Amino Acids
  • Fats
  • Carbohydrates
  • Trace Elements
  • Vitamins
  • Minerals
  • Others

Market, By Consumer, 2016 - 2027 (USD Million)

  • Children and Newborns
  • Adult

Market, By End-use, 2016 - 2027 (USD Million)

  • Hospitals
  • Clinics
  • Homecare
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea 
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
       

Frequently Asked Questions (FAQ) :

Market size of parenteral nutrition accounted for more than USD 5.3 billion in 2020 and will grow at a CAGR of 7.4% from 2021 to 2027.
Amino acids recorded USD 2.03 million valuation in 2020 and will register appreciable growth due to the rising prevalence of protein-energy malnutrition diseases.
Homecare will register a growth rate of 7.2% through 2027 owing to the surging demand for cost effective healthcare delivery, increasing elderly population, and the surging patient preference for home-based care.
The U.S. market will account for a revenue of USD 1.70 billion through 2027 driven by favorable government initiatives, increasing metabolic disorders & other chronic diseases, and growing malnutrition.

Premium Report Details

  • Published Date: Aug 2021
  • Pages: 165
  • Tables: 185
  • Charts / Figures: 16
  • Companies covered: 12
  • Countries covered: 18

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X